Leveragen

Biotechnology ResearchMassachusetts, United States11-50 Employees

Leveragen is a Boston-based biotechnology company advancing antibody discovery through its proprietary Singularity Suite and Universality Suite of genetically engineered mouse models. These platforms generate either fully human single-domain antibodies or common light-chain antibodies with broad epitope coverage and natural in-vivo maturation, enabling the production of diverse, high-quality binders. By integrating advanced immunization strategies with phage display and NGS-guided expansion workflows, Leveragen accelerates the discovery of versatile antibody panels for therapeutic and diagnostic applications across modalities such as bispecifics, ADCs, mRNA, and cell therapies.

Sign up for free to view info

Email Format Employee directory